Mesencephalic human neural progenitor cells transplanted into the neonatal hemiparkinsonian rat striatum differentiate into neurons and improve motor behaviour

Journal of Anatomy

Volumn 209, Issue 6, 2006, Pages 721-732

  Hovakimyan, Marine ^a   Haas, Stefan Jean Pierre ^a   Schmitt, Oliver ^a   Gerber, Bernd ^a   Wree, Andreas ^a   Andressen, Christian ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Cell therapy; Growth factors; Neural stem cell transplantation; Parkinson's disease; Substantia nigra

Indexed keywords

APOMORPHINE; CELL MARKER; CELL NUCLEUS ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; NEURON SPECIFIC ENOLASE; OXIDOPAMINE; PROTEIN S100B; TYROSINE 3 MONOOXYGENASE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN SLICE; CELL COUNT; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; FEMALE; FOREFOOT; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LATERAL BRAIN VENTRICLE; LOCOMOTION; MESENCEPHALON; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEWBORN; NONHUMAN; PARENCHYMA; PARKINSONISM; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; STEM CELL TRANSPLANTATION;

ANIMALS; ANIMALS, NEWBORN; BRAIN TISSUE TRANSPLANTATION; CELL DIFFERENTIATION; CORPUS STRIATUM; DOPAMINE; FEMALE; FETAL TISSUE TRANSPLANTATION; HUMANS; MESENCEPHALON; MICROSCOPY, FLUORESCENCE; MODELS, ANIMAL; MOTOR ACTIVITY; NEURAL PATHWAYS; NEURONS; PARKINSON DISEASE; RATS; RATS, WISTAR; STEM CELL TRANSPLANTATION;

ANIMALIA;

EID: 33751234266     PISSN: 00218782     EISSN: 14697580     Source Type: Journal    
DOI: 10.1111/j.1469-7580.2006.00654.x     Document Type: Article

References (55)

1. Andressen C, Briese V, Ulfig N (2003) Progenitor cells from human embryonic retina - proliferation and preferential differentiation into ganglion cells. Neuroembryology 2, 123-129.
2. Ben-Hur T, Idelson M, Khaner H, et al. (2004) Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem Cells 22, 1246-1255.
3. Bernheimer H, Birkmayer W, Hornykiewiez O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20, 415-455.
4. Betarbet R, Turner R, Chockkan V, et al. (1997) Dopaminergic neurons intrinsic to the primate striatum. J Neurosci 17, 6761-6768.
5. Björklund A, Lindvall O (2000) Cell replacement therapies for central nervous system disorders. Nat Neurosci 3, 537-544.
6. Bouvier MM, Mytilineou C (1995) Basic fibroblast growth factor increases division and delays differentiation of dopamine precursors in vitro. J Neurosci 15, 7141-7149.
7. Brundin P, Isacson O, Gage F, Björklund A (1986) Intrastriatal grafting of dopaminecontaining neural cell suspensions: Effects of mixing with target or non-target cells. Brain Res 389, 77-87.
8. Burnstein RM, Foltynie T, He X, Menon DK, Svendsen CN, Caldwell MA (2004) Differentiation and migration of long term expanded human neural progenitors in a partial lesion model of Parkinson's disease. Int J Biochem Cell Biol 36, 702-713.
9. Calof AL (1995) Intrinsic and extrinsic factors regulating vertebrate neurogenesis. Curr Opin Neurobiol 5, 19-27.
10. Campos LS, Leone DP, Relvas JB, et al. (2004) β1 integrins activate a MAPK signalling pathway in neural stem cells that contributes to their maintenance. Development 131, 3433-3444.
11. Carpenter MK, Cui X, Hu Z, et al. (1999) In vitro expansion of a multipotent population of human neural progenitor cells. Exp Neurol 158, 265-278.
12. Carvey PM, Ling ZD, Sortwell CE, et al. (2001) A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: A source of cells for transplantation in Parkinson's disease. Exp Neurol 171, 98-108.
13. Chalmers-Redman RM, Priestley T, Kemp JA, Fine A (1997) In vitro propagation and inducible differentiation of multipotential progenitor cells from human fetal brain. Neuroscience 76, 1121-1128.
14. Chaturvedi RK, Agrawal AK, Seth K, et al. (2003) Effect of glial cell line-derived neurotrophic factor (GDNF) co-transplantation with fetal ventral mesencephalic cells (VMC) on functional restoration in 6-hydroxydopamine (6-OHDA) lesioned rat model of Parkinson's disease: neurobehavioral, neurochemical and immunohistochemical studies. Int J Dev Neurosci 21, 391-400.
15. Clarke CE, Guttman M (2002) Dopamine agonist monotherapy in Parkinson's disease. Lancet 360, 1767-1769.
16. Cunningham MG, McKay RDG (1993) A hypothermic miniaturized stereotaxic instrument for surgery in newborn rats. J Neurosci Meth 47, 104-114.
17. Dunnett SB, Hernandez TD, Summerfield A, Jones GH, Arbuthnott G (1988) Graft-derived recovery from 6-OHDA lesions: Specificity of ventral mesencephalic graft tissues. Exp Brain Res 71, 411-424.
18. Englund U, Fricker-Gates RA, Lundberg C, Björklund A, Wictorin K (2002) Transplantation of human neural progenitor cells into the neonatal rat brain: Extensive migration and differentiation with long-distance axonal projections. Exp Neurol 173, 1-21.
19. Espejo EF, Gonzalez-Albo MC, Moraes JP, et al. (2001) Functional regeneration in a rat Parkinson's model after intrastriatal grafts of glial cell line-derived neurotrophic factor and transforming growth factor beta1-expressing extra-adrenal chromaffin cells of the Zuckerkandl's organ. J Neurosci 21, 9888-9895.
20. Freed CR, Greene PE, Breeze RE, et al. (2001) Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344, 710-719.
21. Freed WJ, Morihisa JM, Spoor E, et al. (1981) Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behavior. Science 292, 351-352.
22. Fricker RA, Carpenter MK, Winkler C, Greco C, Gates MA, Björklund A (1999) Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain. J Neurosci 19, 5990-6005.
23. Gage FH (2000) Mammalian neural stem cells. Science 287, 1433-1438.
24. Grothe C, Timmer M, Scholz T, et al. (2004) Fibroblast growth factor-20 promotes the differentiation of Nurr1-overexpressing neural stem cells into tyrosine hydroxylase-positive neurons. Neurobiol Dis 17, 163-170.
25. Hagell P, Brundin P (2001) Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease. J Neuropathol Exp Neurol 60, 741-752.
26. Hirsch E, Graybiel AM, Agid YA (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334, 345-348.
27. Iancu R, Mohapel P, Brundin P, Paul G (2005) Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice. Behav Brain Res 162, 1-10.
28. Jeyasingham RA, Baird AL, Meldrum A, Dunnett SB (2001) Differential effects of unilateral striatal and nigrostriatal lesions on grip strength, skilled paw reaching and drug-induced rotation in the rat. Brain Res Bull 55, 541-548.
29. Kilpatrick TJ, Richards LJ, Bartlett PF (1995) The regulation of neural precursor cells within the mammalian brain. Mol Cell Neurosci 6, 2-15.
30. Kirik D, Rosenblad C, Björklund A, Mandel RJ (2000) Long-term, rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system. J Neurosci 20, 4686-4700.
31. Kodama Y, Hida H, Jung CG, et al. (2004) High titer retroviral gene transduction to neural progenitor cells for establishment of donor cells for neural transplantation to parkinsonian model rats. Neurol Med Chir 44, 344-351.
32. Kwon YK (2002) Effect of neurotrophic factors on neuronal stem cell death. J Biochem Mol Biol 35, 87-93.
33. Lee CS, Sauer H, Björklund A (1996) Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat. Neuroscience 72, 641-653.
34. Li XK, Guo AC, Zuo PP (2003) Survival and differentiation of transplanted neural stem cells in mice brain with MPTP-induced Parkinson disease. Acta Pharmacol Sin 24, 1192-1198.
35. McKay RD (1997) Stem cells in the central nervous system. Science 276, 66-71.
36. Miyata T, Kawaguchi A, Okano H, Ogawa M (2001) Asymmetric inheritance of radial glial fibers by cortical neurons. Neuron 31, 727-741.
37. Nakao N, Frodl EM, Duan WM, Widner H, Brundin P (1994) Lazaroids improve the survival of grafted embryonic dopamine neurons. Proc Natl Acad Sci USA 91, 12408-12412.
38. Nikkhah G, Cunningham MG, McKay RDG, Björklund A (1995a) Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA-lesions. I. Evidence for anatomical reconstruction of the nigrostriatal pathway. J Neurosci 15, 3548-3561.
39. Nikkhah G, Cunningham MG, McKay RDG, Björklund A (1995b) Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA-lesions. II. Transplant-induced behavioral recovery. J Neurosci 15, 3562-3570.
40. Otsu N (1979) A threshold selection method from gray level histograms. IEEE Trans Sys Man Cyb 9, 62-66.
41. Rosser AE, Tyers P, Dunnett SB (2000) The morphological development of neurons derived from EGF- and FGF-2-driven human CNS precursors depends on their site of integration in the neonatal rat brain. Eur J Neurosci 12, 2405-2413.
42. Roybon L, Christophersen NS, Brundin P, Li JY (2004) Stem cell therapy for Parkinson's disease: Where do we stand? Cell Tissue Res 318, 261-273.
43. Shimohama S, Sawada H, Kitamura Y, Taniguchi T (2003) Disease model: Parkinson's disease. Trends Mol Med 9, 360-365.
44. Shults CW, Ray J, Tsuboi K, Gage FH (2000) Fibroblast growth factor-2-producing fibroblasts protect the nigrostriatal dopaminergic system from 6-hydroxydopamine. Brain Res 883, 192-204.
45. Snyder EY, Deitcher DL, Walsh C, Arnold-Aldea S, Hartwieg EA, Cepko CL (1992) Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 68, 33-51.
46. Storch A, Paul G, Csete M, et al. (2001) Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells. Exp Neurol 170, 317-325.
47. Studer L, Tabar V, McKay RD (1998) Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat Neurosci 1, 290-295.
48. Sun ZH, Lai YL, Zeng WW, Zhao D, Zuo HC, Xie ZP (2003) Neural stem/ progenitor cells survive and differentiate better in PD rats than in normal rats. Acta Neurochir 87 (Suppl.), 169-174.
49. Svendsen CN, Clarke DJ, Rosser AE, Dunnett SB (1996) Surival and differentiation of rat and human epidermal growth factor-responsive precursor cells following grafting into the lesioned adult central nervous system. Exp Neurol 137, 376-388.
50. Svendsen CN, ter Borg MG, Armstrong RJ, et al. (1998) A new method for the rapid and long term growth of human neural precursor cells. J Neurosci Meth 85, 141-152.
51. Ungerstedt U, Arbuthnott GW (1970) Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 24, 485-493.
52. Vescovi AL, Parati EA, Gritti A, et al. (1999) Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation. Exp Neurol 156, 71-83.
53. Wang X, Lu Y, Zhang H, et al. (2004) Distinct efficacy of pre-differentiated versus intact fetal mesencephalon-derived human neural progenitor cells in alleviating rat model of Parkinson's disease. Int J Dev Neurosci 22, 175-183.
54. Yang M, Donaldson AE, Marshall CE, Shen J, Iacovitti L (2004) Studies on the differentiation of dopaminergic traits in human neural progenitor cells in vitro and in vivo. Cell Transplant 13, 535-547.
55. Yurek DM, Lu W, Hipkens S, Wiegand SJ (1996) BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons. Exp Neurol 137, 105-118.